We demonstrated that YTHDF1 knockdown decreased PRKDC mRNA and DNA‐PKcs protein levels and reversed the changes in osteosarcoma sensitivity to anlotinib induced by METTL3 overexpression. This evidence concerns the gene YTHDF1 and osteosarcoma.